Literature DB >> 9311600

Uterine carcinosarcoma is derived from a single stem cell: an in vitro study.

I Gorai1, T Yanagibashi, A Taki, K Udagawa, E Miyagi, T Nakazawa, F Hirahara, Y Nagashima, H Minaguchi.   

Abstract

Expression of intermediate filaments (IFs) has been suggested to be a reliable marker for differentiating epithelial and non-epithelial tumors. Moreover, the c-erbB-2 and p53 genes are considered to be involved relatively early in the process of human carcinogenesis. In order to elucidate the origin of uterine carcinosarcomas, we analyzed IF, c-erbB-2 and p53 expression in and the ultrastructural characteristics of clones derived from a human uterine-carcinosarcoma cell line, EMTOKA. The expression of IFs and other proteins in the EMTOKA clones was identical to that in the EMTOKA cell line. It and its 7 clones all expressed cytokeratins 8, 17, 18 and 19, vimentin, epithelial membrane antigen, S-100, myoglobin, type-II collagen, alpha-smooth-muscle actin, placental alkaline phosphatase and epidermal-growth-factor receptor. The c-erbB-2 and p53 expression levels of all the cell types of the EMTOKA cell line and its clones were the same. Interestingly, an ultrastructural study showed that the EMTOKA cell line and its clones at early and late passages possessed the characteristics of epithelial cell types without either transitional forms between the epithelial and stromal components or differentiation into sarcomatous components. The results of this study lend particular support to the combination tumor hypothesis that a precursor (stem) cell gives rise both to epithelial and to mesenchymal components during the histogenesis of uterine carcinosarcoma, the epithelial component of which appears to be dominant, suggesting that the established cell lines derived from a common stem cell.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311600     DOI: 10.1002/(sici)1097-0215(19970904)72:5<821::aid-ijc19>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

2.  Treatment of pure uterine sarcoma at the Institut Català D'Oncologia.

Authors:  Gonçalo Fernandez; Susanna Marín I Borràs; Valentín Navarro Pérez; Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2013-01-16

Review 3.  Coexistence of homologous-type cervical carcinosarcoma with endometrioid-type G1 endometrial cancer: a case report with an immunohistochemical study.

Authors:  Andrzej Semczuk; Eva Colas; Beata Walczyna; Maciej Joźwik; Andrzej Pyra; Anna Semczuk-Sikora; Tomasz Rechberger
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  MicroRNA signatures differentiate uterine cancer tumor subtypes.

Authors:  Elena S Ratner; David Tuck; Christine Richter; Sunitha Nallur; Rajeshvari M Patel; Vince Schultz; Pei Hui; Peter E Schwartz; Thomas J Rutherford; Joanne B Weidhaas
Journal:  Gynecol Oncol       Date:  2010-06-09       Impact factor: 5.482

Review 5.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 6.  Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.

Authors:  I A Voutsadakis
Journal:  Clin Transl Oncol       Date:  2012-04       Impact factor: 3.405

7.  Establishment and characterization of JHUCS-1 cell line derived from carcinosarcoma of the human uterus.

Authors:  Kyosuke Yamada; Toshiaki Tachibana; Yasushi Iida; Kazu Ueda; Akihiko Misawa; Nagazumi Suzuki; Hiroyuki Takahashi; Hiroyuki Kato; Eizo Kimura; Makoto Yasuda; Tadao Tanaka; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2004-09       Impact factor: 4.174

8.  Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.

Authors:  Gloria S Huang; Rebecca C Arend; Maomi Li; Marc J Gunter; Lydia G Chiu; Susan Band Horwitz; Gary L Goldberg
Journal:  Am J Obstet Gynecol       Date:  2009-02-06       Impact factor: 8.661

Review 9.  Uterine sarcoma 2008.

Authors:  Jeff F Lin; Brian M Slomovitz
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

10.  Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.

Authors:  Alexander Schipf; Doris Mayr; Thomas Kirchner; Joachim Diebold
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.